# Question 37

**Type:** Survival Analysis - Gene Alteration

**Question:** Do ovarian cancer patients with BRCA1 or BRCA2 alterations have significantly different overall survival compared to wild-type patients?

**Answer:**

**URL**: https://www.cbioportal.org/results/comparison?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=ov_tcga_pan_can_atlas_2018&case_set_id=ov_tcga_pan_can_atlas_2018_cnaseq&data_priority=0&gene_list=BRCA1%2520BRCA2&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=ov_tcga_pan_can_atlas_2018_gistic&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=ov_tcga_pan_can_atlas_2018_mutations&profileFilter=mutations%2Cfusion%2Cgistic&tab_index=tab_visualize

I've routed you to the **Comparison/Survival** page in cBioPortal for the TCGA PanCancer Atlas 2018 Ovarian Cancer study, with BRCA1 and BRCA2 queried.

**What you'll see:**
- The page automatically groups patients into "Altered" (those with BRCA1/BRCA2 mutations or copy number alterations) vs "Unaltered" (wild-type) groups
- Navigate to the **Survival** tab to view Kaplan-Meier curves comparing overall survival between these groups
- Statistical significance (log-rank p-value) will be displayed on the survival plot
- You can also explore other clinical outcomes and molecular differences between the groups using the other tabs

This will allow you to directly assess whether BRCA1/BRCA2 alterations are associated with survival differences in ovarian cancer patients.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 8.491991278948262
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 558
- **output_tokens**: 422
- **total_tokens**: 980
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:38:33*